The efficacy and safety of Yupingfeng Powder with variation in the treatment of allergic rhinitis: Study protocol for a randomized, double-blind, placebo-controlled trial

The efficacy and safety of Yupingfeng Powder with variation in the treatment of allergic rhinitis: Study protocol for a randomized, double-blind, placebo-controlled trial

Background: Allergic rhinitis (AR) is an upper airways chronic inflammatory disease mediated by IgE, which affects 10%–20% of the population. The mainstay for allergic rhinitis nowadays include steroids and antihistamines, but their effects are less than ideal. Many patients therefore seek Chinese m...

Full description

Bibliographic Details
Main Authors: Pui Kuan Cheong, Tin Muk Ho, Kam Leung Chan, Cho Wing Lo, Sin Bond Leung, Kam Lun Hon, Ka Chun Leung, Tony Hon Chung Siu, Tian-He Song, Hongwei Zhang, Jessica Yuet Ling Ching, Tak Yee Chow, Chi Him Sum, Chon Pin Chia, Zhi-Xiu Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Pharmacology
Subjects:
allergic rhinitis
Yupingfeng Powder
randomized control trial
Chinese medicine
IgE
efficacy and safety
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.1058176/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.1058176/full

Similar Items